human apotransferrin

BIOLOGICAL2 trials

Sponsors

Prothya Biosolutions

Conditions

Congenital Atransferrinemiaβ-thalassemia Intermedia

Phase 2

Apotransferrin in Atransferrinemia

Active, not recruitingNCT01797055

Prothya BiosolutionsCongenital Atransferrinemia

Start: 2010-12-01End: 2028-01-01Updated: 2026-09-16

Apotransferrin in Patients With β-thalassemia

TerminatedNCT03993613

Prothya Biosolutionsβ-thalassemia Intermedia

Start: 2019-03-21End: 2022-03-31Updated: 2022-08-15